Candida fungi cause common infections and form tough biofilms that resist treatment. These fungi stick to body surfaces using proteins called adhesins that form amyloid-like structures. Researchers found that special peptides can block these amyloid structures in several Candida species, preventing them from sticking to cells and potentially offering a new way to fight these infections.
Researchers in Japan discovered that a dangerous fungus called Aspergillus latus, previously unknown in the country, has been causing infections since at least 2013. This fungus is difficult to identify because it looks similar to other related species and is actually a hybrid created from two different Aspergillus species. The study found seven cases of this fungus in clinical samples and discovered that it is resistant to some common antifungal medications, making accurate identification crucial for proper patient treatment.
This study tested a new laboratory technology called VITEK® MS for quickly identifying mold infections in patients. Researchers tested the system on 67 mold samples representing 35 different species. The technology successfully identified over 91% of the mold samples accurately without any misidentifications, making it a reliable tool for hospitals to quickly determine what type of mold is causing an infection so doctors can prescribe the right antifungal medication.
Researchers developed a new genetic fingerprinting test to track and identify outbreaks of a dangerous fungal infection called Trichosporon asahii in hospitals across South America. The test uses microsatellite markers to create a detailed genetic profile of different fungal isolates, making it much better at detecting when infections spread from patient to patient compared to older methods. This discovery revealed multiple hidden disease clusters in hospitals, including one that occurred over 13 years, highlighting the importance of this new surveillance tool for hospital infection control.
This study examined how pharmacy students could help improve the use of fluconazole, a common antifungal medication, in hospitals. Researchers found that nearly one-third of fluconazole prescriptions were not being used appropriately. By having pharmacy students participate in reviewing prescriptions under expert supervision, hospitals could better identify problems and educate future pharmacists, while the students gained valuable real-world experience in patient care.
This case series describes five patients from India who developed a serious fungal infection in their jaw and mouth after dental procedures. All patients had uncontrolled diabetes, which weakened their immune system and allowed the fungus to grow. The infection was treated with anti-fungal medications and surgery, and most patients recovered well. The study emphasizes the importance of keeping dental equipment sterile and managing blood sugar levels properly before dental work.
This study reveals that Poland has a significant but underreported problem with serious fungal infections affecting thousands of people annually. The most common fungal infections are yeast infections like candidosis, while mold infections like aspergillosis are the most serious in immunocompromised patients. The research shows that current reporting systems severely underestimate the true burden of these infections, highlighting the need for better surveillance and diagnostic practices.
This study examined 48 patients with serious mould and fungal infections at a South African hospital between 2014-2017. Most infections occurred in people with weak immune systems, especially those with HIV. The most common fungal type was Aspergillus. Even with appropriate antifungal medicines, one-quarter of patients died, highlighting how serious these infections can be.
This comprehensive review reveals that Rwanda faces significant challenges from fungal infections affecting humans, crops, and food security, yet has very limited systems to detect, report, or manage these infections. The study found various dangerous fungi causing infections ranging from vaginal candidiasis to serious disseminated infections, as well as crop-destroying soil fungi threatening bean production. The researchers emphasize that Rwanda urgently needs better diagnostic tools, trained healthcare workers, and coordinated public health strategies to combat the growing threat of fungal diseases.
During the COVID-19 pandemic, fungal infections became a major health concern, especially in hospitalized patients. Treatments for COVID-19, such as steroids and immunosuppressive drugs, weakened patients’ immune systems, making them vulnerable to serious fungal infections like those caused by Candida auris. Current antifungal medications have significant side effects and many fungi are developing resistance, so scientists are urgently seeking safer and more effective antifungal treatments.